Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia

scientific article published on 22 August 2011

Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NEUROSCIENCE.2011.08.038
P698PubMed publication ID21884762
P5875ResearchGate publication ID51613041

P2093author name stringE D Levin
O A Timofeeva
P407language of work or nameEnglishQ1860
P921main subjectcognitive dysfunctionQ57859955
schizophreniaQ41112
P304page(s)21-36
P577publication date2011-08-22
P1433published inNeuroscienceQ15708571
P1476titleGlutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia
P478volume195

Reverse relations

cites work (P2860)
Q33556019A mutation in the extracellular domain of the α7 nAChR reduces calcium permeability
Q37708588ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
Q99612947Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyond
Q28081379Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research
Q47663423Basic Neuroscience Illuminates Causal Relationship Between Sleep and Memory: Translating to Schizophrenia
Q37643422Behavioral and Biochemical Interaction Between Nicotine and Chronic Unpredictable Mild Stress in Mice
Q30624044Cholinergic systems are essential for late-stage maturation and refinement of motor cortical circuits
Q30415168Chronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia
Q38124448Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings
Q22241226Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder
Q30408061Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats
Q37561567Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.
Q46490757Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats
Q30391389Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats
Q38761405Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior
Q37286287Ethanolic Extract of the Seed of Zizyphus jujuba var. spinosa Ameliorates Cognitive Impairment Induced by Cholinergic Blockade in Mice
Q36887530Genetic Relationship between Schizophrenia and Nicotine Dependence
Q34312433Gintonin, a ginseng-derived novel ingredient, evokes long-term potentiation through N-methyl-D-aspartic acid receptor activation: involvement of LPA receptors
Q43200385Impact of adolescent sucrose access on cognitive control, recognition memory, and parvalbumin immunoreactivity.
Q30454141Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses
Q42434820Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo
Q42220961Low-dose memantine-induced working memory improvement in the allothetic place avoidance alternation task (APAAT) in young adult male rats.
Q30462575Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait
Q36936920Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
Q26861923Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals
Q42947034Nicotinic α7 receptor activation selectively potentiates the function of NMDA receptors in glutamatergic terminals of the nucleus accumbens
Q98156748Parvalbumin interneuron vulnerability and brain disorders
Q38669116Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid
Q36729255Prefrontal lactate predicts exercise-induced cognitive dysfunction in Gulf War Illness
Q48434259Reducing amyloid-related Alzheimer's disease pathogenesis by a small molecule targeting filamin A.
Q35913188Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid
Q43795854Role of α7- and α4β2-nAChRs in the neuroprotective effect of nicotine in stress-induced impairment of hippocampus-dependent memory
Q37663640Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring
Q36174107Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia
Q30416030Smoking in schizophrenic patients: A critique of the self-medication hypothesis
Q34945268Top-down beta rhythms support selective attention via interlaminar interaction: a model
Q38060562Wnt signaling: role in Alzheimer disease and schizophrenia
Q34581117Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors

Search more.